Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02313194 · ClinicalTrials.gov registry record · Phase 1
Spinal Cord Neuromodulation for Spinal Cord Injury
A Phase 1 study of Tetraplegia and Cervical Spinal Cord Injury, sponsored by University of California, Los Angeles.
- Active
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02313194: Active Phase 1 study of Tetraplegia and Cervical Spinal Cord Injury, sponsored by University of California, Los Angeles.
NCT02313194 is a Phase 1 study of Tetraplegia and Cervical Spinal Cord Injury that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 12 participants, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02313194, a Phase 1 study of Tetraplegia and Cervical Spinal Cord Injury, is active but no longer recruiting, sponsored by University of California, Los Angeles.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.
Primary Outcome
Formal motor testing
Conditions Studied
Interventions
- DEVICE Epidural Stimulation
- DRUG Buspirone
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-07 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 1 |
What the registry record for NCT02313194 still lists
NCT02313194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 19-participant average among 23 other Tetraplegia trials with a reported enrollment target (37% lower).
The record links to 3 conditions, with Tetraplegia appearing as the primary indexed condition, and to 2 interventions - of which Epidural Stimulation is the first listed.
NCT02313194 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02313194 about?
NCT02313194 is a clinical study titled "Spinal Cord Neuromodulation for Spinal Cord Injury". This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.
What is the current status of trial NCT02313194?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2013-07. Estimated completion is 2026-12-30.
What conditions does trial NCT02313194 study?
This clinical trial studies the following conditions: Tetraplegia, Cervical Spinal Cord Injury, Tetraparesis.
What interventions are being tested in trial NCT02313194?
The interventions under investigation include: Epidural Stimulation (DEVICE), Buspirone (DRUG).
Who is sponsoring clinical trial NCT02313194?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02313194 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tetraplegia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02313194's enrollment target sits among peer trials
12 12th of 23 higher than 11 of 23 other Tetraplegia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tetraplegia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Evaluation of an Advanced Lower Extremity Neuroprostheses
RECRUITING · NA
-
Nerve Transfers Plus Electrical Stimulation to Improve Hand Function in Cervical Spinal Cord Injury
RECRUITING
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
RECRUITING · NA
-
Investigation on the Cortical Communication (CortiCom) System
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia